Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma. - Abstract - Europe PMC
Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer | SpringerLink
New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma | SpringerLink
Sonidegib: mechanism of action, pharmacology, and clinical utility for | OTT
Sonidegib - an overview | ScienceDirect Topics
Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update | Future Oncology
Sonidegib Phosphate
Sonidegib Phosphate
Targeting the Hedgehog Pathway Holds Promises and Pitfalls
![PDF] Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8e476a9c49780bf38ebb73175bec4b850d243f92/2-Figure1-1.png "PDF] Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas | Semantic Scholar")
PDF] Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas | Semantic Scholar
![PDF] Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8e476a9c49780bf38ebb73175bec4b850d243f92/3-Figure2-1.png "PDF] Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas | Semantic Scholar")
PDF] Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas | Semantic Scholar
Frequently Asked Questions about Odomzo® (Sonidegib) - CancerConnect
Sonidegib - LiverTox - NCBI Bookshelf
Cells | Free Full-Text | Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer | HTML
Hedgehog signaling, vismodegib action, and acquired resistance | Download Scientific Diagram
Hedgehog signaling inhibitors in solid and hematological cancers - Cancer Treatment Reviews
Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis | Acta Neuropathologica Communications | Full Text
Vismodegib: a promising drug in the treatment of basal cell carcinomas | Future Oncology
Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas - ScienceDirect
Ignyta's Cancer Drug Inhibitor of Hedgehog Smoothened Pathway Licensed from Lilly | Cancer Biology
Frontiers | Regulation of Hedgehog Signaling by miRNAs and Nanoformulations: A Possible Therapeutic Solution for Colorectal Cancer | Oncology
Challenging the recalcitrant disease—developing molecularly driven treatments for small cell lung cancer - European Journal of Cancer
Cureus | Hedgehog Pathway Inhibitors: Clinical Implications and Resistance in the Treatment of Basal Cell Carcinoma
Sonidegib Capsules
